Quay Pharma is a contract development manufacturing organisation (CDMO). Since 2002, we have proudly delivered over 250 successful projects and exercised continued improvement whilst remaining true to our core values.
Our proven manufacturing technologies provide a low economic risk, fast entry into human trials, and elevated scale-up to future clinical phases.
We have knowledge and expertise in formulating and developing a wide range of product formats and dosage forms for modified and targeted release within the body.
We are licensed for the clinical and commercial manufacturing of new chemical entities, biologicals and live biotherapeutics in a non-sterile environment.
Our core strength is our people. We invest in the best and only experts with strong scientific backgrounds that underpins our service.